Printer Friendly

PET scan spots breast-cancer receptors.

PET scan spots breast-cancer receptors

Medical researchers see no shortage of applications for positron emission tomography (PET), the imaging technique that pinpoints with near-psychedelic artistry tiny biochemical targets in living patients. The procedure, mostly applied in the brain so far, can map the location of specific chemical receptors by illuminating -- within one to two hours -- the "parking places" of injected, radioactively labeled compounds.

Now scientists have designed a traceable, "hot" analogue of the female hormone estrogen that allows them to distinguish between the two major types of breast tumors -- those with estrogen receptors and those without. The former are often responsive to relatively innocuous drugs that block the tumor-enhancing effects of estrogen. The latter require more aggressive treatment as soon as possible.

Until now, cancer specialists had no way of differentiating between the two tumor types in vivo. Researchers can measure estrogen-receptor densities on biopsied specimens. But with secondary, or metastatic, tumors often difficult to find or biopsy -- and with many metastases lacking estrogen receptors even when the primary tumor may have many -- months could pass before a physician finds that anti-estrogen therapy is not working.

Michael J. Welch and his colleagues at the Washington University School of Medicine in St. Louis and John A. Katzenellenbogen of the University of Illinois in Urbana-Champaign injected into 10 women diagnosed with breast cancer an estrogen analogue containing positron-emitting fluorine-18. As confirmed by laboratory tests on biopsied specimens, they correctly identified breast tumors with estrogen receptors as well as estrogen-receptor-rich metastatic tumors in the lymph nodes and the chest wall. Ongoing tests will tell whether PET data can predict the success of estrogen-blocking therapies, the researchers report in the October RADIOLOGY.
COPYRIGHT 1988 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1988, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:positron emission tomography
Author:Weiss, Rick
Publication:Science News
Date:Oct 29, 1988
Words:278
Previous Article:Puzzling particle showers point to pulsars.
Next Article:Muscles in space forfeit more than fibers.
Topics:


Related Articles
RESEARCHER'S PET PROJECT DIAGNOSIS DEVICE POINTS TO REVOLUTION IN MEDICINE.
ENCINO SCIENTIST'S PET SCAN WINS PRESTIGIOUS AWARD.
UNCLOAKING CANCER; RESEARCHERS DEVISE NEW WAYS OF DETECTING THE INVADING CELLS.
Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography.
Complementary role of positron emission tomography in Merkel cell carcinoma.
Fluorodeoxyglucose F 18 positron emission tomography scanning in thoracic disease.
Diagnosis of benign solitary fibrous tumors by positron emission tomography.
The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters